REDWOOD SHORES, Calif., Oct. 23, 2019 /PRNewswire/ — Oracle Health Sciences, a leader in eClinical technology and Phlexglobal, pioneers in the provision of Trial Master File (TMF) technology and services for the global life sciences industry, have announced...
BeyondSpring Inc. (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced that the Company has enrolled its first patient in a Phase 3, Study 106, clinical trial with its lead...
$90 million award expected from the National Institute of Aging and the National Heart, Lung, & Blood Institute to fund largest pragmatic trial with placebo-controlled drug assignment to date In the first statin trial with a non-cardiovascular primary outcome,...
Sofinnova Partners – Life sciences-focused venture capital firm based in Paris, closed its latest fund, Sofinnova Capital IX, oversubscribed at €333 million. The firm now has more than €2B under management with more than €1B raised in the last four years across its...
Third first-in-human cancer treatment trial to open at U of M in last two months MINNEAPOLIS, MN- October 21, 2019 – A new cancer clinical trial has opened at the M Health Fairview University of Minnesota Medical Center that leverages the groundbreaking research...
Mark Terry of BioSpace writes: Pfizer announced results from its Phase III clinical trial, JADE MONO-1, of abrocitinib in moderate to severe atopic dermatitis. The drug met all the co-primary and key secondary endpoints related to skin clearance and itch relief...
Email
Text